Startups Using AI to Support Clinical Decision for IVF and a Self-Test for Sexually-Transmitted Infections Each win CHf 40'000
10.06.2020
Inanna Fertility and ribolifeDx Teams win Venture Kick’s financial and entrepreneurial support. Their projects help more couples to get a successful IVF and anyone to rapidly self-test sexually-transmitted infections.
2.jpg) |
 |
 Inanna Fertility CSO Mohamed Shilaih and CEO Amra Waegli
|
|
 ribolifeDx, Dr. Siew-Veena Sahi
|
|
Inanna Fertility: AI Clinical Decision Support for IVF (www.venturekick.ch/Inanna)
The global infertility crisis is beyond doubt - 72m or 1 in 8 couples experience fertility problems every year and 40% of women diagnosed with infertility suffer from depression or anxiety. Inanna Fertility's vision is that no in-vitro-fertilization (IVF) cycle is lost to trial&error as they connect the dots enabling data-driven clinical decision making powered by AI in fertility. Dr. Prof. B. Leeners from the Department of Repr. Endocrinology of the Universtiy Spital Zurich and CEO Amra Waegli aim to provide decision algorithms to fertility clinics supporting all major steps of the IVF process. They strive to dramatically improve success rates lowering the emotional, financial & medical burden of IVF through a new clinical standard based on personalized treatment recommendations. They will use the Venture Kick's funds to ramp up the research & development team with data scientist, and computer engineers to accelerate development of Inanna solution.
The global infertility crisis is beyond doubt - 72m or 1 in 8 couples experience fertility problems every year and 40% of women diagnosed with infertility suffer from depression or anxiety. Inanna Fertility's vision is that no in-vitro-fertilization (IVF) cycle is lost to trial&error as they connect the dots enabling data-driven clinical decision making powered by AI in fertility. Dr. Prof. B. Leeners from the Department of Repr. Endocrinology of the Universtiy Spital Zurich and CEO Amra Waegli aim to provide decision algorithms to fertility clinics supporting all major steps of the IVF process. They strive to dramatically improve success rates lowering the emotional, financial & medical burden of IVF through a new clinical standard based on personalized treatment recommendations. They will use the Venture Kick's funds to ramp up the research & development team with data scientist, and computer engineers to accelerate development of Inanna solution.
ribolifeDx: Rapid Self-Test for Sexually-Transmitted Infections
The WHO estimates that nearly one million people become infected every day with any of four curable sexually transmitted infections (STIs): chlamydia, gonorrhoea, syphilis, and trichomoniasis. Dr. Siew-Veena Sahi, from the University of Geneva, Dr. Gianpaolo Rando, Brij Sahi and Didier Cowling co-founded ribolifeDx to provides a rapid, self-administered test for sexually-transmitted infections. This replaces an existing, expensive DNA test that can only be performed by technicians in the laboratory, and takes up to 7 days to deliver results. From a user perspective, ribolifeDx's solution is equivalent to a pregnancy test - a reliable disposable self-test, providing a rapid result that can be easily interpreted by anyone, anytime. Their patented DNA isothermal technology is already used commercially in the food industry by SwissDeCode. Their digital, connected test captures the result, time & date stamp, geolocation data - and uploads this to a paired app for fast, actionable results by remote healthcare professionals. The Venture Kick funds will go towards completing their proof-of-concept & creating the minimum viable product.